Where I see patients (1)
Selected research
-
Sequential Targeting in Multiple Myeloma: Talquetamab, a GPRC5D bispecific antibody, as a Bridge to BCMA CAR-T cell therapy.
Blood
-
Emerging GPRC5D-Targeted therapies for multiple myeloma: a comprehensive review.
Expert opinion on investigational drugs
-
Extramedullary disease but not paraskeletal disease portends inferior outcomes after CAR T cell therapy in multiple myeloma.
Bone marrow transplantation